After its longtime chief was ousted last year following a proxy battle, Masimo has now appointed a new CEO. | The medtech has ...

Interim CEO Michelle Brennan Named Chairman of Masimo’s Board IRVINE, Calif., January 21, 2025--(BUSINESS WIRE)--Today the Board of Directors (the "Board") of Masimo (NASDAQ: MASI), a leading ...

Interim CEO Michelle Brennan, who was backed by the activist investor, was appointed chairman of Masimo's board, and Politan founder Quentin Koffey was named the vice-chairman. The new ...

(This Jan. 21 story has been corrected to fix the share price gain to 57% from 45% in paragraph 6) (Reuters) - Masimo named Becton Dickinson executive Katie Szyman as its top boss, the medical device ...

Masimo MASI1.29%increase; green up pointing triangle appointed Katie Szyman as its next chief executive officer after a proxy fight forced out the company’s founder. Szyman will become CEO of ...

Masimo (MASI) announced that Katie Szyman has been appointed the next Chief Executive Officer of the Company. Interim CEO Michelle Brennan has been appointed Chairman of Masimo’s Board and Lead ...

Today the Board of Directors (the “Board”) of Masimo (NASDAQ: MASI), a leading global medical innovator, announced that Katie Szyman has been appointed the next Chief Executive ...

Masimo Corp. today announced Katie Szyman as its new chief executive, effective Feb. 12. Szyman is currently worldwide president of BD Advanced Patient Monitoring, the former Critical Care unit of ...

Masimo Corp. selected Catherine (Katie) Szyman, an industry leader with deep med-tech roots, to guide the company as it seeks to rebuild its reputation and revenues following a gritty two-year battle ...

In examining recent analyst actions, we gain insights into how financial experts perceive Masimo. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings ...